The glioblastoma multiforme signaling as described in the IPA, is characterized by the overexpression/amplification of Receptor Tyrosine Kinases (RTKs) and by the activation of the WNT signaling (Supplementary Table S2). This evidence concerns the gene NTRK1 and glioblastoma.